Pages that link to "Q34102834"
Jump to navigation
Jump to search
The following pages link to Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection? (Q34102834):
Displaying 50 items.
- Disruption of a GATA4/Ankrd1 signaling axis in cardiomyocytes leads to sarcomere disarray: implications for anthracycline cardiomyopathy (Q21134606) (← links)
- Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress (Q26780547) (← links)
- Exercise Prevention of Cardiovascular Disease in Breast Cancer Survivors (Q26785410) (← links)
- Cardiac toxicity in cancer survivors (Q26851957) (← links)
- PET Metabolic Biomarkers for Cancer (Q28074449) (← links)
- Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs (Q28087776) (← links)
- The Use of Chemical-Chemical Interaction and Chemical Structure to Identify New Candidate Chemicals Related to Lung Cancer (Q28395836) (← links)
- Disordering of human telomeric G-quadruplex with novel antiproliferative anthrathiophenedione (Q28477964) (← links)
- ROCK1 deficiency enhances protective effects of antioxidants against apoptosis and cell detachment (Q28540406) (← links)
- Dissecting the Mechanisms of Doxorubicin and Oxidative Stress-Induced Cytotoxicity: The Involvement of Actin Cytoskeleton and ROCK1 (Q28546141) (← links)
- Cancer therapy modulates VEGF signaling and viability in adult rat cardiac microvascular endothelial cells and cardiomyocytes (Q28564571) (← links)
- Cancer drug related cardiotoxicity during breast cancer treatment (Q30251498) (← links)
- Phylogenetic origin of LI-cadherin revealed by protein and gene structure analysis. (Q30341525) (← links)
- Chemotherapy-Induced Cardiotoxicity: Pathophysiology and Prevention (Q30399577) (← links)
- Heart failure following cancer treatment: characteristics, survival and mortality of a linked health data analysis. (Q31120288) (← links)
- Molecular remodeling of left and right ventricular myocardium in chronic anthracycline cardiotoxicity and post-treatment follow up. (Q33578496) (← links)
- Advances in iron chelation: an update (Q34174307) (← links)
- Adult Acute Myeloid Leukemia Long-term Survivors (Q34202366) (← links)
- Chemotherapy-induced cardiotoxicity (Q34258080) (← links)
- Stem cell therapy and breast cancer treatment: review of stem cell research and potential therapeutic impact against cardiotoxicities due to breast cancer treatment (Q34441749) (← links)
- Anthracycline-associated cardiotoxicity in survivors of childhood cancer (Q34626238) (← links)
- Isorhamnetin protects against doxorubicin-induced cardiotoxicity in vivo and in vitro (Q34749618) (← links)
- Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress (Q35222202) (← links)
- Anthracycline treatment and ventricular remodeling in left ventricular assist device patients. (Q35246219) (← links)
- Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients (Q35623306) (← links)
- Apoptosis in Anthracycline Cardiomyopathy (Q35642302) (← links)
- Downregulation of doxorubicin-induced myocardial apoptosis accompanies postnatal heart maturation (Q35900967) (← links)
- An Alpha-1A Adrenergic Receptor Agonist Prevents Acute Doxorubicin Cardiomyopathy in Male Mice (Q36247553) (← links)
- Molecular mechanisms of cardiotoxicity induced by ErbB receptor inhibitor cancer therapeutics (Q36396421) (← links)
- Iron chelators with topoisomerase-inhibitory activity and their anticancer applications (Q36568915) (← links)
- Ataxia telangiectasia mutated in cardiac fibroblasts regulates doxorubicin-induced cardiotoxicity (Q36702443) (← links)
- Early cardiac function monitoring for detection of subclinical Doxorubicin cardiotoxicity in young adult patients with breast cancer (Q36998127) (← links)
- A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology (Q37052852) (← links)
- Distinct roles for ROCK1 and ROCK2 in the regulation of cell detachment (Q37073549) (← links)
- A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor. (Q37293202) (← links)
- Chemotherapy against cancer during pregnancy: A systematic review on neonatal outcomes (Q37300632) (← links)
- Chemotherapy-Induced Left Ventricular Dysfunction in Patients with Breast Cancer (Q37547962) (← links)
- Chemotherapy-induced cardiomyopathy (Q37867085) (← links)
- Early detection of chemotherapy-related left ventricular dysfunction (Q37993439) (← links)
- Rodent models of heart failure: an updated review. (Q37996857) (← links)
- Treatment of the elderly patient with diffuse large B cell lymphoma (Q37998553) (← links)
- Effects of chemotherapy during pregnancy on the maternal and fetal heart. (Q38003095) (← links)
- Drug-induced oxidative stress and toxicity (Q38037517) (← links)
- Cardiac toxicity of anticancer agents (Q38091377) (← links)
- EACVI/HFA Cardiac Oncology Toxicity Registry in breast cancer patients: rationale, study design, and methodology (EACVI/HFA COT Registry)--EURObservational Research Program of the European Society of Cardiology (Q38368230) (← links)
- Intra-patient Variability of FDG Standardized Uptake Values in Mediastinal Blood Pool, Liver, and Myocardium during R-CHOP Chemotherapy in Patients with Diffuse Large B-cell Lymphoma (Q38407450) (← links)
- Mechanisms and management of doxorubicin cardiotoxicity (Q38473474) (← links)
- Role of Drug Metabolism in the Cytotoxicity and Clinical Efficacy of Anthracyclines (Q38576762) (← links)
- Cardiac complications in childhood cancer survivors treated with anthracyclines (Q38588167) (← links)
- Cardiac spheroids as promising in vitro models to study the human heart microenvironment. (Q38647934) (← links)